Literature DB >> 8291598

Aqueous humor penetration of ofloxacin given by various routes.

S von Gunten1, D Lew, F Paccolat, P Vaudaux, P D Brazitikos, P M Leuenberger.   

Abstract

We studied the aqueous humor penetration of ofloxacin after topical, oral, and intravenous administration in 51 consecutive patients undergoing cataract surgery. Aqueous humor concentration (mean +/- SD) was 0.53 +/- 0.35 mg/l when ofloxacin 0.3% eyedrops were instilled topically six times, one drop every three hours, until 90 minutes preoperatively, and 0.63 +/- 0.29 mg/l (P = .45) when two additional instillations were made, one drop every 30 minutes, until 30 minutes before aqueous humor aspiration. Aqueous humor concentration two hours after a single 200-mg oral dose (0.38 +/- 0.15 mg/l) was significantly lower (P = .048) than that 12 hours after the same oral dose (0.58 +/- 0.24 mg/l). Two hours following an intravenous infusion of 200 mg of ofloxacin, aqueous humor concentration was 0.33 +/- 0.19 mg/l. Our results suggest that therapeutic levels above the minimum inhibitory concentration for many bacteria cultured in endophthalmitis can be achieved in aqueous humor after either topical or oral administration, which indicates that this antibiotic passes easily through the corneal and the blood aqueous barriers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291598     DOI: 10.1016/s0002-9394(14)73019-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

2.  Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora.

Authors:  J P Leeming; J P Diamond; R Trigg; L White; H B Hoh; D L Easty
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.